UK's New AI Supercomputer for HC/Drug Development
Cambridge 1 Being Built By US-Based Nvidia
For Drug Discoveries and Treatments in COVID World
Graphics chip maker Nvidia, based in California, is creating the UK's fastest AI supercomputer for drug discoveries and treatments particularly for Covid-19. The supercomputer is called Cambridge 1. It will go on line by the end of 2020 as the world's 29th most powerful AI supercomputer and the most powerful in the UK. The participants in the UK health care AI supercomputer effort are impressive. They include GlaxoSmithKline (GSK), AstraZeneca, King's College, 2 London Hospitals and Oxford Nanopore.
Other Components to This Health Care Discovery Effort
GSK and Nvidia have also build a London based AI lab for vaccine and treatment discovery. And Nvidia has proposed a $40 billion purchase of Cambridge UK based Arm, one of the UK's most successful tech companies specializing in semiconductor chip and software design. This is another example of the technological and global business race to bulk-up and defeat pathogens like Covid-19.